245 related articles for article (PubMed ID: 11518831)
1. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; van Leeuwen WJ; Asarfi A; van Rijn RR; Drop SL;
Pediatr Res; 2001 Sep; 50(3):417-22. PubMed ID: 11518831
[TBL] [Abstract][Full Text] [Related]
2. A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial.
Sass TC; De Muinck Keizer-Schrama SM; Stijnen T; Asarfi A; Van Leeuwen WJ; Van Teunenbroek A; Van Rijn RR; Drop SL
Clin Endocrinol (Oxf); 2000 May; 52(5):531-6. PubMed ID: 10792330
[TBL] [Abstract][Full Text] [Related]
3. The effects of long-term growth hormone treatment on cardiac left ventricular dimensions and blood pressure in girls with Turner's syndrome. Dutch Working Group on Growth Hormone.
Sas TC; Cromme-Dijkhuis AH; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; Drop SL
J Pediatr; 1999 Oct; 135(4):470-6. PubMed ID: 10518081
[TBL] [Abstract][Full Text] [Related]
4. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
[TBL] [Abstract][Full Text] [Related]
5. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Massa GG; Rouwe CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 1999 Dec; 84(12):4607-12. PubMed ID: 10599727
[TBL] [Abstract][Full Text] [Related]
6. Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch experience. The Dutch Advisory Group on Growth Hormone.
de Muinck Keizer-Schrama S; Van den Broeck J; Sas T; Hokken-Koelega A
Horm Res; 1999; 51 Suppl 3():127-31. PubMed ID: 10592457
[TBL] [Abstract][Full Text] [Related]
7. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
[TBL] [Abstract][Full Text] [Related]
8. Body proportions during long-term growth hormone treatment in girls with Turner syndrome participating in a randomized dose-response trial.
Sas TC; Gerver WJ; de Bruin R; Stijnen T; de Muinck Keizer-Schrama SM; Cole TJ; van Teunenbroek A; Drop SL
J Clin Endocrinol Metab; 1999 Dec; 84(12):4622-8. PubMed ID: 10599729
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study. Dutch Advisory Group on Growth Hormone.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; Aanstoot HJ; Drop SL
J Clin Endocrinol Metab; 2000 Feb; 85(2):769-75. PubMed ID: 10690889
[TBL] [Abstract][Full Text] [Related]
10. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; Hokken-Koelega AC; Waelkens JJ; Massa GG; Vulsma T; Gerver WJ; Reeser HM; Delemarre-van de Waal HE; Jansen M; Drop SL
Arch Dis Child; 1999 Jan; 80(1):36-41. PubMed ID: 10325756
[TBL] [Abstract][Full Text] [Related]
11. Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone.
Bertelloni S; Cinquanta L; Baroncelli GI; Simi P; Rossi S; Saggese G
Horm Res; 2000; 53(2):72-6. PubMed ID: 10971092
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density in Turner's syndrome and the influence of pubertal development.
Nadeem M; Roche EF
Acta Paediatr; 2014 Jan; 103(1):e38-42. PubMed ID: 24354573
[TBL] [Abstract][Full Text] [Related]
13. The effects of growth hormone treatment on bone mineral density and body composition in girls with turner syndrome.
Ari M; Bakalov VK; Hill S; Bondy CA
J Clin Endocrinol Metab; 2006 Nov; 91(11):4302-5. PubMed ID: 16940444
[TBL] [Abstract][Full Text] [Related]
14. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
Lanes R
Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
[TBL] [Abstract][Full Text] [Related]
15. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome.
Ross JL; Long LM; Feuillan P; Cassorla F; Cutler GB
J Clin Endocrinol Metab; 1991 Aug; 73(2):355-9. PubMed ID: 1856266
[TBL] [Abstract][Full Text] [Related]
16. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
[TBL] [Abstract][Full Text] [Related]
17. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
[TBL] [Abstract][Full Text] [Related]
18. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
[TBL] [Abstract][Full Text] [Related]
19. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome.
Van Pareren YK; De Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Drop SL
J Clin Endocrinol Metab; 2002 Dec; 87(12):5442-8. PubMed ID: 12466334
[TBL] [Abstract][Full Text] [Related]
20. [The effect of primary lack of estrogens and the influence of the age at the beginning of estrogen therapy on bone mineral density in patients with Turner's syndrome].
Sowińska-Przepiera E; Andrysiak-Mamos E; Friebe Z; Kapczuk K; Pilarska K
Endokrynol Pol; 2005; 56(2):145-53. PubMed ID: 16335682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
